triple monoamine reuptake inhibitorMetabolic PeptidesVerified Match

Tesofensine

A triple monoamine reuptake inhibitor (serotonin, norepinephrine, dopamine) originally developed for Parkinsons and Alzheimers. Repurposed for obesity with Phase 3 showing ~10% weight loss. Not a peptide but often discussed alongside.

weight-lossappetite-suppressionmonoamine-reuptakeexperimental
Best vendor: Pure Health Peptides
3D Structure
3D Structure
383.89 Da
44 atoms
Molecular Weight383.89 Da
FormulaC17H23Cl2NO
PubChem CID11370864
Lab Tested
Yes
Harmful Ingredients
0
Contaminants
None
Tested Purity
98.0%
Batch Consistency
UNKNOWN
Mass Spec Profile
Intensity165211257304350m/z328.1
ESI-MS (computed)
Batch Info
Latest Batch#UNKNOWN
Total Tests1
Unique Vendors1
Vendor Comparison
VendorStatus
P
Pure Health Peptides
Top Choice
Analysis Summary
Purity Standard
Passes (≥98%) — 98.0%
Lab Reports
1 report on file
Summary

A triple monoamine reuptake inhibitor (serotonin, norepinephrine, dopamine) originally developed for Parkinsons and Alzheimers. Repurposed for obesity with Phase 3 showing ~10% weight loss. Not a pept…